SunOpta (NASDAQ:STKL – Get Free Report) (TSE:SOY) released its quarterly earnings results on Tuesday. The company reported $0.02 EPS for the quarter, hitting analysts’ consensus estimates of $0.02, Zacks reports. SunOpta had a negative net margin of 2.74% and a positive return on equity of 7.92%. The firm had revenue of $176.22 million during the quarter, compared to analysts’ expectations of $172.30 million. SunOpta updated its FY 2024 guidance to EPS.
SunOpta Trading Up 2.6 %
NASDAQ:STKL opened at $7.45 on Friday. SunOpta has a one year low of $3.81 and a one year high of $7.59. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.61 and a current ratio of 1.20. The firm has a 50-day simple moving average of $6.30 and a 200-day simple moving average of $5.89.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on STKL shares. Stephens boosted their price objective on shares of SunOpta from $9.00 to $10.00 and gave the company an “overweight” rating in a research report on Wednesday. StockNews.com cut shares of SunOpta from a “hold” rating to a “sell” rating in a research report on Friday, November 1st. Finally, DA Davidson reissued a “buy” rating and issued a $9.00 price objective on shares of SunOpta in a research report on Thursday, October 10th. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $9.50.
SunOpta Company Profile
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Recommended Stories
- Five stocks we like better than SunOpta
- Trading Halts Explained
- Take-Two Interactive’s 2024 Comeback: New Highs Expected in 2025
- What does consumer price index measure?
- How Altimmune Could Grab a Big Chunk of the GLP-1 Market
- How is Compound Interest Calculated?
- Here’s Why Etsy Management Is Investing $1 Billion in Buybacks
Receive News & Ratings for SunOpta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta and related companies with MarketBeat.com's FREE daily email newsletter.